tenofovir has been researched along with tenofovir disoproxil fumarate in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Boojamra, CG; Cihlar, T; Douglas, J; Grant, D; Hui, H; Kim, CU; Laflamme, G; Mackman, RL; Parrish, J; Prasad, V; Stoycheva, AD; Swaminathan, S; Wang, K; Zhang, L | 1 |
| Jiang, JD; Li, YP; Li, ZR; Liu, ZY; Peng, ZG; Tang, YB | 1 |
| Almond, MR; Buckheit, RW; Hartman, T; Keilholz, L; Lampert, BM; Lanier, ER; Mankowski, MK; Osterling, MC; Painter, GR; Ptak, RG | 1 |
| Giesler, KE; Liotta, DC; Marengo, J | 1 |
| Giesler, KE; Liotta, DC | 1 |
| Andrei, G; Buckheit, RW; De Jonghe, S; Groaz, E; Hartman, T; Herdewijn, P; Kalkeri, R; Luo, M; Ptak, RG; Schols, D; Snoeck, R | 1 |
| Li, L; Li, X; Li, Y; Liu, M; Lv, K; Ma, C; Tao, Z; Wang, A; Wu, S | 1 |
| Baszczyňski, O; Chalupský, K; Dračínský, M; Dvořáková, A; Hodek, J; Janeba, Z; Kalčic, F; Mertlíková-Kaiserová, H; Šebestík, J; Strmeň, T; Weber, J; Zgarbová, M | 1 |
8 other study(ies) available for tenofovir and tenofovir disoproxil fumarate
| Article | Year |
|---|---|
Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs.
Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Viral; Magnetic Resonance Spectroscopy; Methane; Molecular Structure; Nucleosides; Organophosphorus Compounds; Prodrugs; Thymidine | 2007 |
Some new acyclic nucleotide analogues as antiviral prodrugs: synthesis and bioactivities in vitro.
Topics: Antiviral Agents; Cells, Cultured; Drug Design; Esters; Hepatitis B virus; HIV-1; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Nucleotides; Prodrugs | 2007 |
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.
Topics: Adenine; Anti-HIV Agents; Cell Survival; Cells, Cultured; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Macrophages; Nucleosides; Nucleotides; Organophosphonates; Tenofovir | 2010 |
Reduction Sensitive Lipid Conjugates of Tenofovir: Synthesis, Stability, and Antiviral Activity.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Hep G2 Cells; Hepatitis B virus; HIV-1; Humans; Leukocytes, Mononuclear; Lipids; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tenofovir | 2016 |
Next-Generation Reduction Sensitive Lipid Conjugates of Tenofovir: Antiviral Activity and Mechanism of Release.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Hepatitis B virus; HIV-1; Lipids; Microbial Sensitivity Tests; Molecular Structure; Prodrugs; Structure-Activity Relationship; Tenofovir | 2016 |
Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs.
Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Aspartic Acid; Cell Line; Cytomegalovirus; Drug Resistance, Viral; Drug Stability; Esters; Hepatitis B virus; Herpesvirus 3, Human; Humans; Hydrogen-Ion Concentration; Microsomes, Liver; Nucleosides; Organophosphonates; Prodrugs; Stereoisomerism; Structure-Activity Relationship | 2017 |
Design, Synthesis, and Anti-HBV Activity of New Bis(l-amino acid) Ester Tenofovir Prodrugs.
Topics: | 2019 |
Discovery of Modified Amidate (ProTide) Prodrugs of Tenofovir with Enhanced Antiviral Properties.
Topics: Amides; Antiviral Agents; Drug Discovery; Hepatitis B virus; Hepatocytes; HIV-1; Humans; Microbial Sensitivity Tests; Phenol; Phosphoric Acids; Prodrugs; Stereoisomerism; Tenofovir; Tyrosine | 2021 |